ImmunoGen
IMGN
#2217
Rank
A$12.52 B
Marketcap
A$44.85
Share price
0.00%
Change (1 day)
106.56%
Change (1 year)

Earnings for ImmunoGen (IMGN)

Earnings in 2023 (TTM): -A$90.32 Million

According to ImmunoGen 's latest financial reports the company's current earnings are A$0.28 Billion. In 2022 the company made an earning of -A$0.32 Billion a decrease over its 2021 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoGen from 1989 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$90.32 Million-71.09%
2022 -A$0.32 Billion72.45%
2021 -A$0.19 Billion495.9%
2020 -A$30.41 Million-75.71%
2019 -A$0.13 Billion-44.88%
2018 -A$0.23 Billion99.42%
2017 -A$0.12 Billion
2015 -A$0.15 Billion43.7%
2014 -A$0.11 Billion135.39%
2013 -A$44.29 Million-66.03%
2012 -A$0.14 Billion42.86%
2011 -A$91.25 Million16.68%
2010 -A$78.21 Million32.83%
2009 -A$58.88 Million-1.99%
2008 -A$60.08 Million108.61%
2007 -A$28.8 Million-10.13%
2006 -A$32.05 Million28.86%
2005 -A$24.87 Million120.33%
2004 -A$11.29 Million-61.19%
2003 -A$29.08 Million-16.6%
2002 -A$34.87 Million51.86%
2001 -A$22.96 Million
1999 A$1.29 M-112.68%
1998 -A$10.2 Million-13.41%
1997 -A$11.78 Million-10.87%
1996 -A$13.22 Million-35.66%
1995 -A$20.54 Million-19.21%
1994 -A$25.42 Million-14.49%
1993 -A$29.73 Million23.95%
1992 -A$23.99 Million
1989 -A$10.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B-51,703.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.57 B-26,253.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$17.01 B-18,978.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.31 B-35,945.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.83 B-13,231.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.06 B-14,595.71%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$11.53 B-12,895.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.14 Billion 1,159.30%๐Ÿ‡บ๐Ÿ‡ธ USA